tiprankstipranks
MindMed to Present at Oppenheimer Healthcare Conference
PremiumCompany AnnouncementsMindMed to Present at Oppenheimer Healthcare Conference
17d ago
Psychedelic: atai Life Sciences reports BPL-003 study results
Premium
The Fly
Psychedelic: atai Life Sciences reports BPL-003 study results
22d ago
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety
Premium
Company Announcements
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety
22d ago
Mind Medicine initiated with a Buy at Chardan
PremiumThe FlyMind Medicine initiated with a Buy at Chardan
2M ago
Mind Medicine to be added to Nasdaq Biotechnology Index December 23.
Premium
The Fly
Mind Medicine to be added to Nasdaq Biotechnology Index December 23.
2M ago
MindMed Begins Phase 3 LSD Study for Anxiety
Premium
Company Announcements
MindMed Begins Phase 3 LSD Study for Anxiety
2M ago
MindMed Appoints New Chief to Boost Drug Approvals
PremiumCompany AnnouncementsMindMed Appoints New Chief to Boost Drug Approvals
3M ago
Mind Medicine appoints Gregg Pratt chief regulatory, quality assurance officer
Premium
The Fly
Mind Medicine appoints Gregg Pratt chief regulatory, quality assurance officer
3M ago
Unusually active option classes on open November 15th
Premium
The Fly
Unusually active option classes on open November 15th
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100